Harmonization of Dementia Drug Guidelines (United States and Europe): A Report of the International Working Group for the Harmonization for Dementia Drug Guidelines

2000; Lippincott Williams & Wilkins; Volume: 14; Issue: Supplement Linguagem: Inglês

10.1097/00002093-200000001-00018

ISSN

1546-4156

Autores

Peter J. Whitehouse,

Tópico(s)

Biomedical Ethics and Regulation

Resumo

The International Working Group for the Harmonization of Dementia Drug Guidelines has been active for more than 5 years attempting to improve the efficiency of international drug development. A virtual organization was formed of clinicians, scientists, industries, participants, and regulators from various nations around the world. This article summarizes a variety of conferences and physicians' papers focusing on aspects of trials ranging from diagnosis, assessment, and trial design to pharmacoeconomics and ethics.

Referência(s)